Literature DB >> 22511596

Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.

Katherine R Martin1, Alicia Corlett, Daphne Dubach, Tomris Mustafa, Harold A Coleman, Helena C Parkington, Tobias D Merson, James A Bourne, Sílvia Porta, Maria L Arbonés, David I Finkelstein, Melanie A Pritchard.   

Abstract

People with Down syndrome (DS) exhibit abnormal brain structure. Alterations affecting neurotransmission and signalling pathways that govern brain function are also evident. A large number of genes are simultaneously expressed at abnormal levels in DS; therefore, it is a challenge to determine which gene(s) contribute to specific abnormalities, and then identify the key molecular pathways involved. We generated RCAN1-TG mice to study the consequences of RCAN1 over-expression and investigate the contribution of RCAN1 to the brain phenotype of DS. RCAN1-TG mice exhibit structural brain abnormalities in those areas affected in DS. The volume and number of neurons within the hippocampus is reduced and this correlates with a defect in adult neurogenesis. The density of dendritic spines on RCAN1-TG hippocampal pyramidal neurons is also reduced. Deficits in hippocampal-dependent learning and short- and long-term memory are accompanied by a failure to maintain long-term potentiation (LTP) in hippocampal slices. In response to LTP induction, we observed diminished calcium transients and decreased phosphorylation of CaMKII and ERK1/2-proteins that are essential for the maintenance of LTP and formation of memory. Our data strongly suggest that RCAN1 plays an important role in normal brain development and function and its up-regulation likely contributes to the neural deficits associated with DS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511596     DOI: 10.1093/hmg/dds134

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Tomris Mustafa; Lee E Eiden
Journal:  Sci Signal       Date:  2013-06-25       Impact factor: 8.192

2.  Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.

Authors:  Eun Hye Lee; Seon Sook Kim; Seul Lee; Kwan-Hyuck Baek; Su Ryeon Seo
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

3.  Down syndrome DSCR1 causes spine pathology via the Fragile X-related protein FMRP.

Authors:  Francesco Roselli
Journal:  EMBO J       Date:  2012-08-21       Impact factor: 11.598

Review 4.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  Mutation of the HERC 1 Ubiquitin Ligase Impairs Associative Learning in the Lateral Amygdala.

Authors:  Eva Mª Pérez-Villegas; José V Negrete-Díaz; Mª Elena Porras-García; Rocío Ruiz; Angel M Carrión; Antonio Rodríguez-Moreno; José A Armengol
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

Review 6.  Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome.

Authors:  Karen T Chang; Hyunah Ro; Wei Wang; Kyung-Tai Min
Journal:  Trends Neurosci       Date:  2013-09-25       Impact factor: 13.837

7.  The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.

Authors:  Soojin Lee; Se Min Bang; Yoon Ki Hong; Jang Ho Lee; Haemin Jeong; Seung Hwan Park; Quan Feng Liu; Im-Soon Lee; Kyoung Sang Cho
Journal:  Dis Model Mech       Date:  2015-12-10       Impact factor: 5.758

Review 8.  A central role for calcineurin in protein misfolding neurodegenerative diseases.

Authors:  Syed Zahid Ali Shah; Tariq Hussain; Deming Zhao; Lifeng Yang
Journal:  Cell Mol Life Sci       Date:  2016-09-28       Impact factor: 9.261

9.  Critical role of regulator of calcineurin 1 in spinal cord injury.

Authors:  Guodong Wang; Yilei Zhao; Shenpeng Liu; Jinling Jia; Tan Lu
Journal:  J Physiol Biochem       Date:  2016-06-23       Impact factor: 4.158

10.  RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease.

Authors:  Xiaoyong Li; Lei Shi; Ming Xu; Xun Zheng; Yiwen Yu; Jing Jin
Journal:  Pediatr Cardiol       Date:  2017-10-09       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.